Roivant Sciences Ltd. Common Shares vs Viavi Solutions Inc. Common Stock — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B), while Viavi Solutions Inc. Common Stock trades at $45.32 (market cap $10.85B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.3× Viavi Solutions Inc. Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (6,279,442 versus 4,281,289). Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 1 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| ROIV | VIAV | |
|---|---|---|
Market Cap | $24.72B | $10.85B |
Volume | 6,279,442 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $41.81 | $55.33 |
52-Week Low | $16.04 | $12.27 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $20.99B | $10.89B |
Trailing returns across standard periods
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →